These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Adult Fanconi syndrome secondary to kappa-light chain myeloma: improvement of tubular functions after treatment for myeloma. Uchida S; Matsuda O; Yokota T; Takemura T; Ando R; Kanemitsu H; Hamaguchi H; Miyake S; Marumo F Nephron; 1990; 55(3):332-5. PubMed ID: 2115147 [TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma in patient with multiple myeloma, sideroblastic anaemia, and T-lymphocyte abnormalities. Summerfield GP; Bellingham AJ; Barnes RM; Stewart TW Lancet; 1983 Apr; 1(8329):871-2. PubMed ID: 6132193 [No Abstract] [Full Text] [Related]
26. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma. Gasparetto C; Gockerman JP; Diehl LF; de Castro CM; Moore JO; Long GD; Horwitz ME; Keogh G; Chute JP; Sullivan KM; Neuwirth R; Davis PH; Sutton LM; Anderson RD; Chao NJ; Rizzieri D Biol Blood Marrow Transplant; 2010 Jan; 16(1):70-7. PubMed ID: 19733251 [TBL] [Abstract][Full Text] [Related]
27. Tri-lineage disease involving sideroblastic anaemia, multiple myeloma and B-cell non-Hodgkin's lymphoma in the same patient. Ianotto JC; Tempescul A; Eveillard JR; Marion V; Quintin-Roué I; Berthou C Ann Hematol; 2009 Mar; 88(3):273-4. PubMed ID: 18719917 [No Abstract] [Full Text] [Related]
28. Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages. Dunkley S; Gibson J; Iland H; Li C; Joshua D Leuk Lymphoma; 1999 Nov; 35(5-6):623-6. PubMed ID: 10609802 [TBL] [Abstract][Full Text] [Related]
29. [Follicular mucinosis with generalized para-amyloidosis as a cutaneous paraneoplastic syndrome in myeloma (IgD and light chain plasmacytoma). A demonstration of the course using melphalan-prednisone therapy with a 3 years remission]. Jänner M; Lippert HD; Stolzenbach G Z Hautkr; 1977 Aug; 52(16):873-40. PubMed ID: 408988 [No Abstract] [Full Text] [Related]
30. Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol). Case DC; Sonneborn HL; Paul SD; Hayes DM; Dorsk BM; Carroll RJ; Bove L Oncology; 1985; 42(3):137-40. PubMed ID: 3858763 [TBL] [Abstract][Full Text] [Related]
31. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476 [TBL] [Abstract][Full Text] [Related]
32. [A myeloma (IgG-kappa) terminating in acute myelogenous leukemia]. Fujii H; Yashige H; Taniwaki M; Urata Y; Kuzuyama Y; Kitagawa Y; Horishi M; Suyama Y; Miyoshi M Gan No Rinsho; 1990 Apr; 36(5):645-50. PubMed ID: 2109137 [TBL] [Abstract][Full Text] [Related]
33. Controversies in the treatment of plasma cell myeloma. Bergsagel DE Postgrad Med J; 1985 Feb; 61(712):109-16. PubMed ID: 3983038 [No Abstract] [Full Text] [Related]
35. Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment. Carlson K; Hjorth M; Knudsen LM; Br J Haematol; 2005 Mar; 128(5):631-5. PubMed ID: 15725084 [TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus pneumonia after treatment with melphalan and prednisone. Report of a case. von Eyben F; Olsen TS Acta Med Scand; 1978; 203(4):333-5. PubMed ID: 206105 [TBL] [Abstract][Full Text] [Related]
37. Light chain myeloma with features of the adult Fanconi syndrome: six years remission following one course of melphalan. von Schéele C Acta Med Scand; 1976; 199(6):533-7. PubMed ID: 820162 [TBL] [Abstract][Full Text] [Related]
38. [Scleredema, acanthosis nigricans and IgA/Kappa multiple myeloma]. Valente L; Velho GC; Farinha F; Bernardo A; Ribeiro P; Massa A Ann Dermatol Venereol; 1997; 124(8):537-9. PubMed ID: 9740847 [TBL] [Abstract][Full Text] [Related]
39. Chronic lymphatic leukemia developing in a patient with multiple myeloma: immunologic demonstration of a clonally distinct second malignancy. Zalcberg JR; Cornell FN; Ireton HJ; McGrath KM; McLachlan R; Woodruff RK; Wiley JS Cancer; 1982 Aug; 50(3):594-7. PubMed ID: 7093901 [TBL] [Abstract][Full Text] [Related]
40. Heavy chain loss after treatment with Melphalan in a patient with "nonsecretory" myeloma. Katagiri S; Yonezawa T; Kanayama Y; Tsubakio T; Tamaki T; Kanakura Y; Kurata Y; Tarui S Blut; 1983 Feb; 46(2):73-80. PubMed ID: 6401436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]